CEO: Thorfinn Ege
www.santosolve.com
Business:
SantoSolve was founded in 2001 based on the discovery that strontium can have a strong pain killing effect. Experimental treatments of single patients with a topical strontium-containing formulation indicate a rapid, local pain killing effect on both acute and chronic pain at the site of administration. It is anticipated that SantoSolve's products will be alternative or adjuvant products to systemic therapies used for localized pain.
Contact:
Main office:
SantoSolve AS
Drammensveien 41
0271 Oslo
Norway
Phone: +47 21 37 82 02
post@santosolve.com